![Blood & Cancer artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts123/v4/1e/c2/c2/1ec2c24b-87c4-8ff6-ba9e-d81a8cbb12eb/mza_1867652355606483784.png/100x100bb.jpg)
COVID-19 vaccination in cancer patients: Who should be vaccinated and when?
Blood & Cancer
English - March 04, 2021 09:00 - 30 minutes - 42.1 MB - ★★★★★ - 31 ratingsMedicine Health & Fitness Science Life Sciences oncologists radiotherapy cancer chemotherapy doctors healthcare hematologists hematology immunotherapy marrow Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
When should cancer patients receive a COVID-19 vaccine? The National Comprehensive Cancer Network (NCCN) has issued recommendations to provide guidance on the topic.
Guideline author Steven Pergam, MD, of Fred Hutchinson Cancer Research Center, Seattle, explains NCCN’s recommendations to host David H. Henry, MD, in this episode.
Prioritization
Transplant and cellular therapy
Patients who undergo allogeneic or autologous transplant or those who receive cellular therapy should be vaccinated at least 3 months after this treatment. This recommendation is based on best practices used for other vaccines, as there are insufficient data on COVID-19 vaccination in these patients, Dr. Pergam noted.Hematologic malignancies
For patients with hematologic malignancies receiving intensive cytotoxic chemotherapy, vaccination should be delayed until absolute neutrophil count recovery. Patients with marrow failure from disease, those receiving therapy expected to have limited or no recovery, and those on long-term maintenance therapy should get vaccinated when a vaccine is available to them.Antibody response
There are no current data to support checking antibodies prior to vaccination, as one will lose antibodies over time, Dr. Pergam noted. Likewise, there are no data to support testing for antibodies after vaccination.Solid tumor malignancies
Patients with solid tumor malignancies who are receiving cytotoxic chemotherapy, targeted therapy, radiation, or checkpoint inhibitors or other immunotherapies should be vaccinated when a vaccine is available to them. For patients undergoing surgery, there should be adequate time between receiving a vaccine and the surgical date, as side effects from the vaccine, such as fever, can delay surgery.These guidelines are available for download from the NCCN website: https://www.nccn.org/covid-19/.
Show notes written by Malika Gill, MD, a resident at Pennsylvania Hospital, Philadelphia.
Disclosures
Dr. Pergam and Dr. Henry have no relevant disclosures.
For more MDedge Podcasts, go to mdedge.com/podcasts
Email the show: [email protected]
Interact with us on Twitter: @MDedgehemonc
David Henry on Twitter: @davidhenrymd